Dr. Hinduja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
155 N Fresno St
Fresno, CA 93701Phone+1 559-499-6520
Summary
- Dr. Sanjay Hinduja is an oncologist in Fresno, CA and is affiliated with multiple hospitals in the area, including Clovis Community Medical Center and Community Regional Medical Center. He received his medical degree from Bharti Vidyapeeth Medical College and has been in practice 5 years. He specializes in head & neck cancer and hematologic oncology. He has 3 publications and 14 citings.
Education & Training
University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 2018 - 2021- University of California (San Francisco)/FresnoChief Residency, Internal Medicine, 2017 - 2018
- University of California (San Francisco)/FresnoResidency, Internal Medicine, 2014 - 2017
Bharti Vidyapeeth Medical CollegeClass of 2013, M.D.
Certifications & Licensure
CA State Medical License 2016 - 2026
VA State Medical License 2024 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsEfficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature ReviewSalimah Valliani, Mir Ali, Omar Mahmoo, Sanjay Hinduja, Calvin K. Chen
Case Reports in Hematology. 2020-12-28 - 6 citationsA rare case of choroid plexus carcinoma that led to the diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer).Viola W. Zhu, Sanjay Hinduja, Stevan R. Knezevich, William R. Silveira, Celia D. DeLozier
Clinical Neurology and Neurosurgery. 2017-07-01 - 1 citationsPositive Response to Fluorouracil and Oxaliplatin in Signet Ring Cell Adenocarcinoma of the Bladder Presenting With Retroperitoneal Fibrosis.Sanjay Hinduja, Haifaa Abdulhaq, Salimah Valliani, Mir M Ali
Cureus. 2020-07-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
